Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Sky One Doubles Year-Earlier Revenues in Q1

publication date: May 14, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Sky One Medical (中国天字一号医药公司) reported Q1 revenues hit $24.8 million this year, an exact 100% increase from the year earlier. Net income jumped 87% to $9.1 million, a big rise and a stunning 37% margin on sales. The company attributed its success to its sales force as well as contributions from acquisitions made during 2008. China Sky One also provided full-year 2009 guidance. More details...

Stock Symbol: (NSDQ: CSKI)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...